182 related articles for article (PubMed ID: 21468652)
1. Detection of intestinal metaplasia after successful eradication of Barrett's Esophagus with radiofrequency ablation.
Vaccaro BJ; Gonzalez S; Poneros JM; Stevens PD; Capiak KM; Lightdale CJ; Abrams JA
Dig Dis Sci; 2011 Jul; 56(7):1996-2000. PubMed ID: 21468652
[TBL] [Abstract][Full Text] [Related]
2. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation.
Orman ES; Kim HP; Bulsiewicz WJ; Cotton CC; Dellon ES; Spacek MB; Chen X; Madanick RD; Pasricha S; Shaheen NJ
Am J Gastroenterol; 2013 Feb; 108(2):187-95; quiz 196. PubMed ID: 23247578
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
Gupta M; Iyer PG; Lutzke L; Gorospe EC; Abrams JA; Falk GW; Ginsberg GG; Rustgi AK; Lightdale CJ; Wang TC; Fudman DI; Poneros JM; Wang KK
Gastroenterology; 2013 Jul; 145(1):79-86.e1. PubMed ID: 23499759
[TBL] [Abstract][Full Text] [Related]
4. Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett's esophagus.
Korst RJ; Santana-Joseph S; Rutledge JR; Antler A; Bethala V; DeLillo A; Kutner D; Lee BE; Pazwash H; Pittman RH; Rahmin M; Rubinoff M
J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1529-34. PubMed ID: 23219501
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation.
Guthikonda A; Cotton CC; Madanick RD; Spacek MB; Moist SE; Ferrell K; Dellon ES; Shaheen NJ
Am J Gastroenterol; 2017 Jan; 112(1):87-94. PubMed ID: 27725648
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.
Orman ES; Li N; Shaheen NJ
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1245-55. PubMed ID: 23644385
[TBL] [Abstract][Full Text] [Related]
7. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
Cotton CC; Wolf WA; Overholt BF; Li N; Lightdale CJ; Wolfsen HC; Pasricha S; Wang KK; Shaheen NJ;
Gastroenterology; 2017 Sep; 153(3):681-688.e2. PubMed ID: 28579538
[TBL] [Abstract][Full Text] [Related]
8. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
[TBL] [Abstract][Full Text] [Related]
9. Durability of radiofrequency ablation for long-segment and ultralong-segment Barrett's esophagus over 10 years.
Nguyen CL; Tovmassian D; Zhou M; Seyfi D; Gooley S; Falk GL
Surg Endosc; 2024 Mar; 38(3):1239-1248. PubMed ID: 38092973
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
12. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
Shaheen NJ; Overholt BF; Sampliner RE; Wolfsen HC; Wang KK; Fleischer DE; Sharma VK; Eisen GM; Fennerty MB; Hunter JG; Bronner MP; Goldblum JR; Bennett AE; Mashimo H; Rothstein RI; Gordon SR; Edmundowicz SA; Madanick RD; Peery AF; Muthusamy VR; Chang KJ; Kimmey MB; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Dumot JA; Falk GW; Galanko JA; Jobe BA; Hawes RH; Hoffman BJ; Sharma P; Chak A; Lightdale CJ
Gastroenterology; 2011 Aug; 141(2):460-8. PubMed ID: 21679712
[TBL] [Abstract][Full Text] [Related]
13. The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication.
Johnson CS; Louie BE; Wille A; Dunst CM; Worrell SG; DeMeester SR; Reynolds J; Dixon J; Lipham JC; Lada M; Peters JH; Watson TJ; Farivar AS; Aye RW
J Gastrointest Surg; 2015 May; 19(5):799-805. PubMed ID: 25740341
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of endoscopic submucosal dissection (ESD) plus radiofrequency ablation (RFA) for nodular Barrett's esophagus.
Bahdi F; Katti CC; Mansour N; Gagneja H; Anandasabapathy S; Othman MO
Scand J Gastroenterol; 2023 Feb; 58(2):123-132. PubMed ID: 35968576
[TBL] [Abstract][Full Text] [Related]
15. Predictors of recurrence of dysplasia or cancer in patients with dysplastic Barrett's esophagus following complete eradication of dysplasia: a single-center retrospective cohort study.
Kobayashi R; Calo NC; Marcon N; Iwaya Y; Shimamura Y; Honda H; Streutker C; Mosko J; May G; Teshima C
Surg Endosc; 2022 Jul; 36(7):5041-5048. PubMed ID: 34750708
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of liquid nitrogen cryotherapy after failed radiofrequency ablation for Barrett's esophagus.
Trindade AJ; Inamdar S; Kothari S; Berkowitz J; McKinley M; Kaul V
Dig Endosc; 2017 Sep; 29(6):680-685. PubMed ID: 28303613
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for long- and ultralong-segment Barrett's esophagus: a comparative long-term follow-up study.
Dulai PS; Pohl H; Levenick JM; Gordon SR; MacKenzie TA; Rothstein RI
Gastrointest Endosc; 2013 Apr; 77(4):534-41. PubMed ID: 23290719
[TBL] [Abstract][Full Text] [Related]
18. Length of Barrett's segment predicts failure of eradication in radiofrequency ablation for Barrett's esophagus: a retrospective cohort study.
Luckett T; Allamneni C; Cowley K; Eick J; Gullick A; Peter S
BMC Gastroenterol; 2018 May; 18(1):67. PubMed ID: 29783927
[TBL] [Abstract][Full Text] [Related]
19. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE
Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
[TBL] [Abstract][Full Text] [Related]
20. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
